0001209191-24-001035.txt : 20240105
0001209191-24-001035.hdr.sgml : 20240105
20240105163819
ACCESSION NUMBER: 0001209191-24-001035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240103
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maestas Nicholas
CENTRAL INDEX KEY: 0001871423
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 24516776
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT
STREET 2: SUITE 275
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 20005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tempest Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-798-8589
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 400
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Millendo Therapeutics, Inc.
DATE OF NAME CHANGE: 20181207
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-03
0
0001544227
Tempest Therapeutics, Inc.
TPST
0001871423
Maestas Nicholas
C/O TEMPEST THERAPEUTICS, INC.
2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE
CA
94005
0
1
0
0
VP of Strategy and Finance
0
Employee Stock Option (right to buy)
4.66
2024-01-03
4
A
0
40000
0.00
A
2034-01-02
Common Stock
40000
40000
D
These stock options vest in a series of 48 equal monthly installments measured from January 3, 2024, subject to the Reporting Person's continued service.
/s/ Nicholas Maestas
2024-01-05